NCT04626622View on ClinicalTrials.gov

Kagocel® for the Prevention of ARVI and Influenza in Young People

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

April 26, 2018

Study Completion Date

June 30, 2018

Conditions
Acute Upper Respiratory Tract InfectionInfluenzaRespiratory Viral Infection
Interventions
DRUG

Kagocel

Investigators could prescribe other drugs in frame of routine clinical practice

DRUG

No one

Investigators don't prescribe any antiviral drugs in frame of routine clinical practice

Trial Locations (1)

660022

Krasnoyarsk State Medical University, Krasnoyarsk

All Listed Sponsors
lead

Nearmedic Plus LLC

INDUSTRY

NCT04626622 - Kagocel® for the Prevention of ARVI and Influenza in Young People | Biotech Hunter | Biotech Hunter